Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Heyer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Genes & Cancer|July 23, 2011
KRAS Mouse Models: Modeling Cancer Harboring KRAS MutationsRónán C O'Hagan, Joerg Heyer
Nature Reviews. Cancer|June 25, 2010
Non-germline genetically engineered mouse models for translational cancer researchJoerg Heyer, Lawrence N Kwong, Scott W Lowe, et al.
Molecular and Cellular Biology|December 31, 2005
Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiationWenjun Ju, Atsushi Ogawa, Joerg Heyer, et al.
Science (New York, N.Y.)|March 2, 2002
Colorectal cancer in mice genetically deficient in the mucin Muc2Anna Velcich, WanCai Yang, Joerg Heyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2003
Hierarchical model of gene regulation by transforming growth factor betaYaw-Ching Yang, Ester Piek, Jiri Zavadil, et al.
Personalized Medicine|September 12, 2017
Clinical application of a cancer genomic profiling assay to guide precision medicine decisionsCheryl Eifert, Angeliki Pantazi, Ruobai Sun, et al.
Plos One|August 28, 2014
Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapyYinghui Zhou, William M Rideout, Angela Bressel, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2002
Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progressionMelanie Kucherlapati, Kan Yang, Mari Kuraguchi, et al.
Nature Biotechnology|December 22, 2009
Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomasYinghui Zhou, William M Rideout, Tong Zi, et al.
Cancer Research|November 12, 2009
De novo discovery of a gamma-secretase inhibitor response signature using a novel in vivo breast tumor modelJames W Watters, Chun Cheng, Pradip K Majumder, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Genes & Cancer|July 23, 2011
KRAS Mouse Models: Modeling Cancer Harboring KRAS MutationsRónán C O'Hagan, Joerg Heyer
Nature Reviews. Cancer|June 25, 2010
Non-germline genetically engineered mouse models for translational cancer researchJoerg Heyer, Lawrence N Kwong, Scott W Lowe, et al.
Molecular and Cellular Biology|December 31, 2005
Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiationWenjun Ju, Atsushi Ogawa, Joerg Heyer, et al.
Science (New York, N.Y.)|March 2, 2002
Colorectal cancer in mice genetically deficient in the mucin Muc2Anna Velcich, WanCai Yang, Joerg Heyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2003
Hierarchical model of gene regulation by transforming growth factor betaYaw-Ching Yang, Ester Piek, Jiri Zavadil, et al.
Personalized Medicine|September 12, 2017
Clinical application of a cancer genomic profiling assay to guide precision medicine decisionsCheryl Eifert, Angeliki Pantazi, Ruobai Sun, et al.
Plos One|August 28, 2014
Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapyYinghui Zhou, William M Rideout, Angela Bressel, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2002
Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progressionMelanie Kucherlapati, Kan Yang, Mari Kuraguchi, et al.
Nature Biotechnology|December 22, 2009
Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomasYinghui Zhou, William M Rideout, Tong Zi, et al.
Cancer Research|November 12, 2009
De novo discovery of a gamma-secretase inhibitor response signature using a novel in vivo breast tumor modelJames W Watters, Chun Cheng, Pradip K Majumder, et al.
Pageof 2